Wright Medical Group NV  

(Public, NASDAQ:TRNX)   Watch this stock  
Find more results for TRNX
0.00 (0.00%)
Oct 1 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week     -
Open     -
Vol. 0.00
Mkt cap 2.15B
P/E     -
Div/yield     -
EPS -0.68
Shares 102.66M
Beta     -
Inst. own 42%

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -14.40% -8.54%
Operating margin -11.38% -6.21%
EBITD margin - 6.86%
Return on average assets -6.86% -4.32%
Return on average equity -9.74% -5.87%
Employees 1,121 -
CDP Score - -


Prins Bernhardplein 200
+31-20-6754002 (Phone)
+31-10-4718888 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Wright Medical Group NV, formerly Tornier NV, is a medical device company based in the Netherlands. The Company is focused on providing solutions to surgeons that treat musculoskeletal injuries and disorders of the shoulder, elbow, wrist, hand, ankle and foot, which is refer to as extremity joints. It sells to surgeons a line of joint replacement, trauma, sports medicine and biologic products to treat extremity joints. In certain international markets, it also offers joint replacement products for the hip and knee. The Company offers a product portfolio of over 90 extremities products that are designed to provide solutions to its surgeon customers. Its product portfolio consists product categories, which include upper extremity joints and trauma; lower extremity joints and trauma; sports medicine and biologics, and large joints and other. It conducts local sales and distribution activities in North and South America, Europe, Africa, Asia and Australia.

Officers and directors

Robert J. Palmisano President, Chief Executive Officer, Executive Director
Age: 70
Bio & Compensation  - Reuters
Lance A. Berry CPA Chief Financial Officer, Senior Vice President
Age: 42
Bio & Compensation  - Reuters
Peter S. Cooke President - International
Age: 49
Bio & Compensation  - Reuters
Kevin D. Cordell President - Lower Extremities and Biologics
Age: 49
Bio & Compensation  - Reuters
Terry M. Rich President, Upper Extremities
Age: 47
Bio & Compensation  - Reuters
David H. Mowry Chief Operating Officer, Executive Vice President, Executive Director
Age: 52
Bio & Compensation  - Reuters
J. Wesley Porter Senior Vice President, Chief Compliance Officer
Bio & Compensation  - Reuters
James A. Lightman Senior Vice President, General Counsel, Secretary
Age: 57
Bio & Compensation  - Reuters
William L. Griffin Jr. Senior Vice President and General Manager – BioMimetic Therapeutics
Age: 66
Bio & Compensation  - Reuters
Robert P. Burrows Senior Vice President - Supply Chain
Bio & Compensation  - Reuters